Science activity
Articles (5) More info
| 1 |
Baev D.S.
, Blokhin M.E.
, Chirkova V.Y.
, Belenkaya S.V.
, Luzina O.A.
, Yarovaya O.I.
, Salakhutdinov N.F.
, Shcherbakov D.N.
Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease Molecules. 2023. V.28. N1. P.303. DOI: 10.3390/molecules28010303 WOS Scopus РИНЦ |
| 2 |
Blokhin M.E.
, Kuranov S.O.
, Khvostov M.V.
, Fomenko V.V.
, Luzina O.A.
, Zhukova N.A.
, Elhajjar C.
, Tolstikova T.G.
, Salakhutdinov N.F.
Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome Current Issues in Molecular Biology. 2023. V.45. N3. P.2230-2247. DOI: 10.3390/cimb45030144 WOS Scopus РИНЦ |
| 3 |
Kuranov S.
, Marenina M.
, Ivankin D.
, Blokhin M.
, Borisov S.
, Khomenko T.
, Luzina O.
, Khvostov M.
, Volcho K.
, Tolstikova T.
, Salakhutdinov N.
The Study of Hypoglycemic Activity of 7-Terpenylcoumarins Molecules. 2022. V.27. N24. P.8663. DOI: 10.3390/molecules27248663 WOS РИНЦ |
| 4 |
Fomenko V.
, Blokhin M.
, Kuranov S.
, Khvostov M.
, Baev D.
, Borisova M.S.
, Luzina O.
, Tolstikova T.G.
, Salakhutdinov N.F.
Triterpenic Acid Amides as a Promising Agent for Treatment of Metabolic Syndrome 
Scientia Pharmaceutica. 2021.
V.89. N1. 4
:1-14. DOI: 10.3390/scipharm89010004
WOS
Scopus
РИНЦ
|
| 5 |
Kuranov S.O.
, Blokhin M.E.
, Borisov S.A.
, Khvostov M.V.
, Luzina O.A.
, Salakhutdinov N.F.
Synthesis and Hypoglycemic Activity of Aryl(Hetaryl)Propenoic Cyanopyrrolidine Amides Russian Journal of Bioorganic Chemistry. 2019. V.45. N5. P.374-380. DOI: 10.1134/S1068162019050078 WOS Scopus РИНЦ |
Scopus ID:
ResearcherID:
ORCID: